APG Asset Management N.V. cut its stake in shares of McKesson Corporation (NYSE:MCK – Free Report) by 1.5% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 131,939 shares of the company’s stock after selling 2,022 shares during the quarter. APG Asset Management N.V. owned about 0.11% of McKesson worth $101,928,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in MCK. GGM Financials LLC acquired a new position in shares of McKesson in the third quarter valued at about $25,000. State of Wyoming purchased a new stake in McKesson in the second quarter valued at approximately $29,000. Hopwood Financial Services Inc. acquired a new position in McKesson in the 3rd quarter worth approximately $31,000. Delos Wealth Advisors LLC purchased a new position in McKesson during the 2nd quarter worth approximately $35,000. Finally, Abound Wealth Management lifted its stake in McKesson by 104.3% during the 3rd quarter. Abound Wealth Management now owns 47 shares of the company’s stock valued at $37,000 after acquiring an additional 24 shares during the period. Hedge funds and other institutional investors own 85.07% of the company’s stock.
McKesson Trading Up 1.0%
Shares of MCK stock opened at $984.61 on Friday. McKesson Corporation has a 12-month low of $621.88 and a 12-month high of $987.37. The business’s 50 day moving average is $868.77 and its two-hundred day moving average is $806.54. The company has a market capitalization of $120.60 billion, a P/E ratio of 28.32, a P/E/G ratio of 1.59 and a beta of 0.40.
McKesson Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be given a $0.82 dividend. The ex-dividend date is Monday, March 2nd. This represents a $3.28 annualized dividend and a dividend yield of 0.3%. McKesson’s dividend payout ratio (DPR) is 9.43%.
Wall Street Analyst Weigh In
A number of analysts have recently weighed in on the stock. Robert W. Baird set a $968.00 price objective on shares of McKesson in a research note on Wednesday, January 14th. Wells Fargo & Company upped their price target on shares of McKesson from $914.00 to $925.00 and gave the company an “equal weight” rating in a report on Thursday, February 5th. Wall Street Zen downgraded McKesson from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. JPMorgan Chase & Co. boosted their price objective on McKesson from $983.00 to $1,107.00 and gave the company an “overweight” rating in a report on Tuesday, February 10th. Finally, Morgan Stanley restated an “overweight” rating and issued a $966.00 target price on shares of McKesson in a research note on Thursday, January 29th. Thirteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, McKesson presently has a consensus rating of “Moderate Buy” and an average target price of $943.50.
Check Out Our Latest Stock Analysis on McKesson
Insider Activity at McKesson
In other McKesson news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $955.00, for a total transaction of $313,240.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Leann B. Smith sold 190 shares of McKesson stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $945.00, for a total value of $179,550.00. Following the completion of the sale, the executive vice president directly owned 2,989 shares in the company, valued at $2,824,605. This represents a 5.98% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 1,143 shares of company stock worth $1,046,070 over the last three months. Company insiders own 0.08% of the company’s stock.
McKesson Profile
McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.
The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.
Recommended Stories
- Five stocks we like better than McKesson
- The gold chart Wall Street is terrified of…
- This makes me furious
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.
